Aptar Pharma, a leading provider of innovative drug delivery systems, is delighted to be a Platinum Sponsor at RDD 2018, taking place from April 22-April 26 at the JW Marriott Starr Pass Resort and Spa in Tucson, Arizona.
The RDD conference series is recognized as one of the premier international meetings in the respiratory field, impacting regulatory and scientific policies worldwide. RDD brings together pharmaceutical experts within the medical aerosol community to share innovative research, technology and services of interest.
As part of the Platinum Sponsor Seminars at RDD 2018, two Aptar Pharma experts will present a 40-minute talk on the most recent FDA guidance on Combination Products, and will focus specifically on respiratory and nasal drug products.
The seminar, entitled “Decoding FDA’s Recent Combination Drug Product Guidance: Applications to DPIs, pMDIs, and Nasal Sprays” will be presented by Badre Hammond, Associate Director, Market Development Aptar Pharma Prescription and Wendy Bolf, Regulatory Affairs Manager, Aptar Pharma Prescription.
Aptar Pharma’s Platinum Sponsor Seminar will take place twice on Tuesday, April 24, in Tucson Room I and J, at 8:00 AM and again at 8:45 AM.
Aptar Pharma will host an interactive table, located in the Arizona Ballroom of the JW Marriott Starr Pass Resort and Spa, where our team of experts will showcase our innovative range of MDIs, DPIs and BAIs, demonstrating how they can accelerate speed-to-market by assisting customers from concept to regulatory submission and approval. There will also be a Connectivity Focus, dedicated to the growing field of c-Devices, offering insight into our range of add-on and integrated c-Devices.